Breast and Cervical Cancer Education Program

Breast Cancer Clinical Trial

— OCEAP  

Official title:

OWEL Cancer Education and Awareness Program (OCEAP)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06365450
• Other study ID #: IRB00315481
• Status: Completed
• Phase: N/A
• Start date: September 22, 2022
• Est. completion date: April 5, 2024

Study information

• Verified date: April 2024
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary goal of this study is to improve cancer literacy in Black women living with HIV and ultimately improve breast and cervical cancer screening uptake. This study involves an educational intervention delivered virtually and in person, depending on the participants' preference.

Description:

The aims of this study are to:

1. develop educational materials on breast and cervical cancer screening;

2. administer the intervention using a PowerPoint presentation;

3. evaluate changes in breast and cervical cancer literacy levels after the intervention; and

4. assess participants'; satisfaction with the program

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: April 5, 2024
• Est. primary completion date: February 28, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• able to read and write in English

• self-identify as HIV positive -

• Black/African American.

Exclusion Criteria:

• Acutely ill

Related Conditions & MeSH terms

• Breast Cancer
• Cervical Cancer
• Health Behavior
• Uterine Cervical Neoplasms

Intervention

Other:
• Educational Intervention
Participants will receive hybrid educational intervention on breast and cervical cancer

Locations

Country	Name	City	State
United States	Johns Hopkins University School of Nursing	Baltimore	Maryland

Sponsors (3)

Lead Sponsor	Collaborator
Johns Hopkins University	Older Women Embracing Life, The John G. Bartlett Specialty Practice

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Health Literacy in Cancer Screening as assessed by the Assessment of Health Literacy in Cancer Screening (AHL-C) tool.	The dimensions of health literacy adapted from the AHL-C tool are: Numeracy (2 items); Familiarity (9 items); Comprehension (1 item); Navigation (7 items).; To determine health literacy scores of participants, each item will be scored on a scale of 0 to 1. A higher score would mean a better outcome. Items will be summed for each of the four sub-scales as well as the entire scale (AHL-C) and then determine the mean and standard deviation.; Assessment will be completed immediately post intervention (after two sessions on breast and cervical cancer)	Immediately Post intervention
Secondary	Number of participants recruited from each community partner	Participants recruited from each community partner	Immediately Post intervention
Secondary	Number of participants who preferred virtual or in person sessions	Participant session attendance preference	Immediately Post intervention
Secondary	Number of participants who were lost of follow up	Participants lost to follow up	Immediately post intervention
Secondary	Number of participants who needed help redeeming their gift codes	Participants needing help redeeming gift cards	Immediately post intervention